OTCMKTS:ARKAY - Arkema Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 13
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
▼ -4.07 (-3.22%)
1 month | 3 months | 12 months
Get New Arkema Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARKAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARKAY

Average Price Target: $0.00
▼ -100.00% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for Arkema in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $122.45.


The current consensus among 13 investment analysts is to hold stock in Arkema. This rating has held steady since May 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/10/2021Redburn PartnersUpgradeSell ➝ Neutral
5/18/2021BarclaysReiterated RatingEqual Weight
5/12/2021Credit Suisse GroupReiterated RatingUnderperform
5/11/2021Berenberg BankReiterated RatingHold
5/7/2021JPMorgan Chase & Co.Reiterated RatingOverweight
5/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/30/2021BarclaysReiterated RatingEqual Weight
4/14/2021UBS GroupReiterated RatingNeutral
4/12/2021JPMorgan Chase & Co.Reiterated RatingOverweight
3/9/2021Stifel NicolausUpgradeHold ➝ Buy
3/3/2021Berenberg BankReiterated RatingHold
3/1/2021Kepler Capital MarketsUpgradeHold ➝ Buy
2/2/2021Redburn PartnersDowngradeBuy ➝ Sell
1/26/2021Credit Suisse GroupDowngradeOutperform ➝ Underperform
12/18/2020Societe GeneraleReiterated RatingHold
12/8/2020UBS GroupReiterated RatingNeutral
12/7/2020BarclaysReiterated RatingEqual Weight
12/7/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight
11/6/2020Credit Suisse GroupReiterated RatingOutperform
10/6/2020Morgan StanleyReiterated RatingOverweight
10/5/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/22/2020CitigroupReiterated RatingBuy
8/14/2020HSBCDowngradeBuy ➝ Hold
8/4/2020JPMorgan Chase & Co.Reiterated RatingOverweight
8/3/2020UBS GroupReiterated RatingNeutral
7/13/2020Morgan StanleyReiterated RatingOverweight
7/8/2020UBS GroupReiterated RatingNeutral
6/19/2020Credit Suisse GroupReiterated RatingOutperform
6/1/2020UBS GroupReiterated RatingNeutral
3/30/2020Morgan StanleyReiterated RatingOverweight
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/4/2020The Goldman Sachs GroupUpgradeSell ➝ Buy
2/25/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/4/2020Kepler Capital MarketsUpgradeReduce ➝ Hold
1/16/2020BarclaysDowngradeOverweight ➝ Equal Weight
4/3/2019Berenberg BankInitiated CoverageHold
1/17/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform
11/29/2018MacquarieInitiated CoverageOutperform ➝ Outperform
11/19/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell
11/7/2018Credit Suisse GroupUpgradeHold
11/13/2017Credit Suisse GroupDowngradeNeutral ➝ Underperform
8/8/2017The Goldman Sachs GroupReiterated RatingNeutral
8/3/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral
8/2/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral
7/3/2017CitigroupUpgradeNeutral ➝ Buy
2/13/2017Evercore ISIInitiated CoverageBuy
(Data available from 6/20/2016 forward)
Arkema logo
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. It operates in three segments: Adhesive Solutions, Advanced Materials, and Coating Solutions. Its products include acrylics, coating resins, electroactive polymers, fluorochemicals, fluoropolymers, functional polyolefins, hydrazine hydrate, hydrogen peroxide, molecular sieves, organic peroxide, oxygenated solvents, polyetherketoneketone, plastic additives, polymethyl methacrylate resins and sheets, rheology additives, solutions for glass coating, specialty adhesives, specialty polyamides, surfactants and additives, technical fluids, and thiochemicals. The company also offers UV, LED, EB curable resins, and specialty acrylates. It offers adhesive solutions used in building activities for businesses and individuals, including sealants, tile and flooring adhesives, and waterproofing systems, as well as in automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets; advanced materials used in the automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment; coating solutions for decorative paints, industrial coatings, adhesives, paper, superabsorbents, water treatment, oil and gas extraction, 3D printing, and electronics applications; and industrial intermediate chemicals for the construction, production of refrigeration and air conditioning, automotive, and water treatment applications. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
Read More

Today's Range

Now: $122.45
Low: $122.44
High: $124.64

50 Day Range

MA: $129.04
Low: $122.45
High: $134.33

52 Week Range

Now: $122.45
Low: $89.34
High: $134.33


2,122 shs

Average Volume

2,045 shs

Market Capitalization

$9.40 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Arkema?

The following Wall Street sell-side analysts have issued reports on Arkema in the last twelve months: Barclays PLC, Berenberg Bank, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, JPMorgan Chase & Co., Kepler Capital Markets, Morgan Stanley, Redburn Partners, Societe Generale, Stifel Nicolaus, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for ARKAY.

What is the current price target for Arkema?

0 Wall Street analysts have set twelve-month price targets for Arkema in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Arkema in the next year.
View the latest price targets for ARKAY.

What is the current consensus analyst rating for Arkema?

Arkema currently has 1 sell rating, 7 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ARKAY, but not buy more shares or sell existing shares.
View the latest ratings for ARKAY.

What other companies compete with Arkema?

How do I contact Arkema's investor relations team?

Arkema's physical mailing address is 420 rue d`Estienne d Orves, Colombes Cedex I0, 92700. The basic materials company's listed phone number is 33-1-49-00-80-80 and its investor relations email address is [email protected] The official website for Arkema is www.arkema.com.